Dry Eye Relief
in two minutes
FDA-cleared treatment for MGD-related dry eye
Tixel i® Advanced Dry Eye Treatment
Tixel i® brings a breakthrough approach to treating evaporative dry eye caused by meibomian gland dysfunction (MGD). Using advanced Thermo-Mechanical Action® technology, this FDA-cleared treatment delivers precise, controlled heat through ultra-brief 6-millisecond pulses, gently restoring natural gland function.
Simple Relief. Proven Results.
EFFICIENCY
Complete treatment in just 2 minutes for both eyes
Can be performed by eye care professionals and trained staff
SAFETY & COMFORT
Safe, self-disinfecting titanium-coated tip
Gentle procedure with radiation-free technology
CLINICAL VALIDATION
Proven results backed by multiple clinical studies
Long-lasting relief confirmed in 6-month US multi-center study
Simple Relief. Proven Results.
Tixel i® streamlines dry eye treatment with its 2-minute protocol and delegable procedure. Practices benefit from efficient patient flow while delivering clinically proven results that keep patients satisfied.
SIMPLE BY DESIGN
Quick 2-minute treatment for both eyes
No radiation or anesthesia needed
Gentle procedure that never touches your eye
Trusted and delegated by eye care providers
SIMPLE RECOVERY
Patients return to daily activities immediately
No post-treatment restrictions
Comfortable, straightforward process
SIMPLY EFFECTIVE
Significant symptom improvement reported
Long-lasting results proven over 6 months
Backed by clinical research
Office: 144 E Market Place Blvd.
Knoxville, TN 37922
Call 888-849-3587
Email: [email protected]
Site: www.tixel.us
